NGeneBio Co., Ltd.

NGeneBio aims to become a global precision diagnostic platform company offering innovative precision diagnostic technology and genetic testing services worldwide. NGeneBio has commercialized products for mutations detection in solid tumor tissues from lung cancer, gastric cancer etc., and blood from blood cancer such as acute leukemia. We also provide precision diagnostics products that suggest optimal treatment methods for both solid tumor and blood cancer, and HLA precision diagnostics products that test the donor suitability at the bone marrow transplantation stage. We have supplied them to numerous University General Hospitals in South Korea and actively exported worldwide through international distributors.